The University Of Texas Health Science Center At San Antonio
Clinical trials sponsored by The University Of Texas Health Science Center At San Antonio, explained in plain language.
-
Put your money where your drink is: study tests deposit contracts to curb heavy drinking
Disease control TerminatedThis study aimed to see if asking people to put down a deposit (between $30 and $100) that they could earn back by meeting their drinking goals would help them drink less. Participants would wear a remote alcohol monitor to track their drinking. The study was withdrawn before any…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common drug slow Alzheimer's? new study tests rapamycin
Disease control OngoingThis study tests whether the drug rapamycin is safe and tolerable for older adults with mild memory problems or early Alzheimer's disease. About 40 participants will take rapamycin for 12 months while researchers monitor side effects and changes in memory and thinking. The goal i…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a smartphone app boost opioid treatment success?
Disease control OngoingThis study tests a mobile app called KIOS that gives personalized advice and support to people receiving medication-assisted treatment for opioid use disorder. Over 12 weeks, 116 participants will either use the app plus standard counseling or just standard counseling. The goal i…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New program aims to tackle diabetes in people with mental illness – but study never started
Disease control TerminatedThis study was designed to test whether a program called Lifestyle MIND can help people with serious mental illness (like schizophrenia or bipolar disorder) prevent or manage type 2 diabetes. The program includes group exercise and health classes twice a week for 10 weeks. Howeve…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for essential thrombocythemia patients: experimental drug targets overactive platelet production
Disease control OngoingThis phase 2 trial tests an experimental drug called IMG-7289 in 9 adults with essential thrombocythemia, a rare blood disorder causing too many platelets. The drug aims to lower platelet counts and ease symptoms. Participants take a daily pill, with doses adjusted individually. …
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 26, 2026 15:31 UTC
-
Can monthly Check-Ins boost pain relief from talk therapy?
Symptom relief OngoingThis study tests whether adding monthly booster sessions to standard cognitive behavioral therapy (CBT) helps people with chronic pain manage their symptoms better over 18 months. About 716 military health system beneficiaries with chronic pain will receive either standard CBT or…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jul 01, 2026 23:00 UTC
-
Massive rural health study aims to uncover heart and lung disease risks
Knowledge-focused OngoingThis study is gathering health information from 4,600 people in rural areas of Alabama, Kentucky, Louisiana, and Mississippi. Researchers will look for risk factors that lead to heart and lung disease. No treatments or drugs are being tested. The goal is to learn more about what …
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Dust mite asthma study aims to uncover how dupilumab works inside the body
Knowledge-focused OngoingThis study looks at how dupilumab changes the way the nose and blood respond to house dust mites in adults with allergic asthma. Participants will be exposed to dust mites in a special chamber and receive either dupilumab or a placebo. The goal is to understand the drug's effects…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Muscle recovery differs between sexes, new study reveals
Knowledge-focused OngoingThis study looks at how middle-aged men and women lose muscle after a week of not using one leg, and how they recover with exercise. Researchers will measure muscle strength, size, and genetic activity to find sex-specific differences. The goal is to learn more so future treatmen…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New approach aims to boost cancer trial awareness and participation
Knowledge-focused OngoingThis study tests a communication method to help cancer patients and the general public learn about clinical trials and make informed decisions about joining. About 581 participants will receive information to increase their awareness and positive attitudes toward trials. The goal…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC